Back
Bee Vectoring Technologies International 10K Form
Sell
25
BEE.CX
Bee Vectoring Technologies International
Last Price:
0.01
Seasonality Move:
-1.51%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BEE.CX News And Ratings
See the #1 stock for the next 7 days that we like better than BEE.CX
BEE.CX Financial Statistics
Sales & Book Value
| Annual Sales: | $601.65K |
|---|---|
| Cash Flow: | $38.2K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.01 |
| Price / Book: | 1.81 |
Profitability
| EPS (TTM): | -0.02390 |
|---|---|
| Net Income (TTM): | $-3.66M |
| Gross Margin: | $318.14K |
| Return on Equity: | -167.71% |
| Return on Assets: | -76.75% |
Bee Vectoring Technologies International Earnings Forecast
Key Bee Vectoring Technologies International Financial Ratios
- The Gross Profit Margin over the past 13 years for BEE.CX is 52.88%.
- The Selling, General & Administrative Expenses for BEE.CX have been equal to 523.72% of Gross Profit Margin.
- The Research & Development expenses have been 72.39% of Revenue.
- The Interest Expense is -4.02% of Operating Income.
- The Net Earning history of BEE.CX is -776.99% of Total Revenues.
- Per Share Earnings over the last 13 years have been positive in 5 years.
Bee Vectoring Technologies International Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | CNSX |
|---|---|
| Industry: | Chemicals |
| Sector: | Materials |
| Current Symbol: | BEE.CX |
| Website: | beevt.com |
Debt
| Debt-to-Equity Ratio: | 0.27 |
|---|---|
| Current Ratio: | 0.48 |
| Quick Ratio: | 0.39 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BEE.CX Technical Analysis vs Fundamental Analysis
Sell
25
Bee Vectoring Technologies International (BEE.CX)
is a Sell
Is Bee Vectoring Technologies International a Buy or a Sell?
-
Bee Vectoring Technologies International stock is rated a Sell
The current Bee Vectoring Technologies International [BEE.CX] share price is $0.01. The Score for BEE.CX is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.